Page last updated: 2024-08-21

nsc 65346 and Breast Neoplasms

nsc 65346 has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jung, M; Lee, SA	1
Cappellini, A; Chiarini, F; Martelli, AM; McCubrey, JA; Ognibene, A	1

Other Studies

2 other study(ies) available for nsc 65346 and Breast Neoplasms

Article	Year
The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation. The Journal of biological chemistry, 2007, May-18, Volume: 282, Issue:20 Topics: Anthracenes; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Humans; JNK Mitogen-Activated Protein Kinases; Lamin Type A; MAP Kinase Kinase 4; Neoplasm Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Kinase C-delta; Protein Processing, Post-Translational; Pyrimidine Nucleosides	2007
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast Cell cycle (Georgetown, Tex.), 2009, May-01, Volume: 8, Issue:9 Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Nucleosides; Purines; Pyrimidine Nucleosides; RNA, Messenger; Roscovitine	2009

Article

Year

The nucleoside analog sangivamycin induces apoptotic cell death in breast carcinoma MCF7/adriamycin-resistant cells via protein kinase Cdelta and JNK activation.

The Journal of biological chemistry, 2007, May-18, Volume: 282, Issue:20

Topics: Anthracenes; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Caspases; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Leukemic; Humans; JNK Mitogen-Activated Protein Kinases; Lamin Type A; MAP Kinase Kinase 4; Neoplasm Proteins; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Kinase C-delta; Protein Processing, Post-Translational; Pyrimidine Nucleosides

2007

The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast

Cell cycle (Georgetown, Tex.), 2009, May-01, Volume: 8, Issue:9

Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Nucleosides; Purines; Pyrimidine Nucleosides; RNA, Messenger; Roscovitine

2009